$2.32 Billion is the total value of RTW INVESTMENTS, LP's 65 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 16.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RCKT | Rocket Pharmaceuticals Inc | $234,534,000 | -38.7% | 16,812,491 | 0.0% | 10.10% | -30.1% | |
| ALNY | Buy | Alnylam Pharmaceuticals Inc | $183,047,000 | -3.0% | 1,681,645 | +2.7% | 7.88% | +10.7% |
| PTCT | Buy | PTC Therapeutics Inc | $175,440,000 | -4.7% | 3,932,746 | +2.6% | 7.55% | +8.7% |
| DRNA | Buy | Dicerna Pharmaceuticals Inc | $127,913,000 | -1.2% | 6,963,135 | +18.5% | 5.51% | +12.8% |
| BMY | Buy | Bristol-Myers Squibb Co | $93,974,000 | -10.9% | 1,685,934 | +2.6% | 4.04% | +1.7% |
| STOK | Stoke Therapeutics Inc | $81,163,000 | -19.1% | 3,544,248 | 0.0% | 3.49% | -7.7% | |
| MRTX | Buy | Mirati Therapeutics Inc | $75,730,000 | -8.9% | 985,166 | +52.6% | 3.26% | +3.9% |
| FIXX | Buy | Homology Medicines Inc | $68,364,000 | -24.1% | 4,399,250 | +1.1% | 2.94% | -13.4% |
| ZBH | Buy | Zimmer Biomet Holdings Inc | $67,871,000 | +3.7% | 671,457 | +53.5% | 2.92% | +18.3% |
| MASI | Buy | Masimo Corp | $67,822,000 | +12.3% | 382,915 | +0.2% | 2.92% | +28.1% |
| IMVT | Immunovant Inc | $65,876,000 | -0.3% | 4,426,106 | 0.0% | 2.84% | +13.8% | |
| ADVM | Buy | Adverum Biotechnologies Inc | $64,791,000 | -11.9% | 6,631,627 | +3.8% | 2.79% | +0.5% |
| AXSM | Buy | Axsome Therapeutics Inc | $61,946,000 | -41.6% | 1,052,969 | +2.5% | 2.67% | -33.4% |
| BLU | Buy | Bellus Health Inc New | $54,732,000 | +49.7% | 5,490,992 | +13.4% | 2.36% | +70.7% |
| SRPT | Sell | Sarepta Therapeutics Inc | $51,772,000 | -33.8% | 529,261 | -12.6% | 2.23% | -24.4% |
| AXNX | Buy | Axonics Modulation Technolog | $43,426,000 | -1.5% | 1,709,000 | +7.4% | 1.87% | +12.3% |
| VCEL | Buy | Vericel Corp | $40,905,000 | -21.4% | 4,460,755 | +49.2% | 1.76% | -10.3% |
| NTRA | Buy | Natera Inc | $37,806,000 | +178.5% | 1,266,125 | +214.2% | 1.63% | +217.8% |
| FREQ | Buy | Frequency Therapeutics Inc | $36,888,000 | +69.5% | 2,071,199 | +59.0% | 1.59% | +93.4% |
| TBIO | Buy | Translate Bio Inc | $36,813,000 | +36.8% | 3,692,424 | +11.7% | 1.58% | +56.2% |
| GBT | New | Global Blood Therapeutics In | $36,759,000 | – | 719,489 | +100.0% | 1.58% | – |
| MYOK | Buy | Myokardia Inc | $36,608,000 | -34.0% | 780,898 | +2.6% | 1.58% | -24.7% |
| AVDL | Buy | Avadel Pharmaceuticals plcsponsored adr | $36,253,000 | +41.2% | 4,616,570 | +35.7% | 1.56% | +61.1% |
| OYST | New | Oyster Pt Pharma Inc | $33,932,000 | – | 969,478 | +100.0% | 1.46% | – |
| RLMD | Buy | Relmada Therapeutics Inc | $33,583,000 | +29.6% | 984,542 | +48.2% | 1.45% | +47.9% |
| ESTA | Buy | Establishment Labs Hldgs Inc | $33,512,000 | -40.4% | 2,319,138 | +14.1% | 1.44% | -32.0% |
| AGEN | Buy | Agenus Inc | $32,087,000 | -11.2% | 13,096,625 | +47.5% | 1.38% | +1.3% |
| WVE | Buy | WAVE Life Sciences Ltd | $31,764,000 | +132.4% | 3,389,933 | +98.8% | 1.37% | +164.9% |
| Buy | DermTech Inc | $29,087,000 | +2.4% | 2,600,729 | +9.0% | 1.25% | +16.8% | |
| TNDM | New | Tandem Diabetes Care Inc | $28,554,000 | – | 443,725 | +100.0% | 1.23% | – |
| PRQR | ProQR Thrapeutics N V | $26,237,000 | -44.6% | 4,779,135 | 0.0% | 1.13% | -36.8% | |
| NSTG | Buy | NanoString Technologies Inc | $25,484,000 | +58.2% | 1,059,621 | +83.0% | 1.10% | +80.4% |
| STAA | Buy | STAAR Surgical Co | $21,796,000 | +105.1% | 675,650 | +123.6% | 0.94% | +133.9% |
| CSTL | Buy | Castle Biosciences Inc | $20,811,000 | -4.1% | 698,118 | +10.6% | 0.90% | +9.5% |
| XGN | Buy | Exagen Inc | $20,015,000 | +9.6% | 1,255,640 | +74.7% | 0.86% | +25.1% |
| PTGX | Buy | Protagonist Therapeutics Inc | $18,782,000 | +8.3% | 2,660,392 | +8.1% | 0.81% | +23.5% |
| JNJ | Johnson & Johnson | $15,324,000 | -10.1% | 116,858 | 0.0% | 0.66% | +2.6% | |
| ARVN | Sell | Arvinas Inc | $13,901,000 | -49.5% | 344,937 | -48.5% | 0.60% | -42.4% |
| APYX | Apyx Med Corp | $12,175,000 | -57.6% | 3,391,279 | 0.0% | 0.52% | -51.6% | |
| TXG | Buy | 10x Genomics Inc | $11,848,000 | +3009.7% | 190,109 | +3702.2% | 0.51% | +3542.9% |
| RGNX | Buy | Regenxbio Inc | $10,155,000 | -18.9% | 313,606 | +2.6% | 0.44% | -7.4% |
| ODT | Buy | Odonate Therapeutics Inc | $10,108,000 | -12.7% | 366,085 | +2.6% | 0.44% | -0.5% |
| LJPC | Buy | La Jolla Pharmaceutical Co | $9,890,000 | +10.0% | 2,354,734 | +2.9% | 0.43% | +25.7% |
| MDXG | Sell | MiMedx Group Inc | $9,424,000 | -54.0% | 2,700,320 | -0.1% | 0.41% | -47.5% |
| TELA | Tela Bio Inc | $8,910,000 | -39.6% | 1,139,358 | 0.0% | 0.38% | -31.1% | |
| BWAY | Buy | Brainsway Ltdsponsored ads | $8,793,000 | -5.9% | 1,107,420 | +15.5% | 0.38% | +7.1% |
| CTMX | Buy | Cytomx Therapeutics Inc | $8,182,000 | -5.3% | 1,066,791 | +2.6% | 0.35% | +8.0% |
| MIST | Buy | Milestone Pharmaceuticals In | $7,940,000 | -87.5% | 4,315,102 | +9.0% | 0.34% | -85.7% |
| QURE | Buy | Uniqure NV | $7,406,000 | -32.0% | 156,076 | +2.6% | 0.32% | -22.4% |
| ABUS | Buy | Arbutus Biopharma Corp | $6,938,000 | -56.0% | 6,869,281 | +21.2% | 0.30% | -49.7% |
| CLSD | Buy | Clearside Biomedical Inc | $6,602,000 | -39.3% | 3,883,490 | +3.6% | 0.28% | -30.7% |
| TMDX | Transmedics Group Inc | $6,079,000 | -36.5% | 503,266 | 0.0% | 0.26% | -27.4% | |
| ITMR | New | Itamar Med Ltdsponsored ads | $5,386,000 | – | 457,218 | +100.0% | 0.23% | – |
| INMD | Inmode Ltd | $5,375,000 | -45.2% | 250,000 | 0.0% | 0.23% | -37.6% | |
| LSACU | New | Lifesci Acquisition Corpunit 03/31/2025 | $4,999,000 | – | 500,000 | +100.0% | 0.22% | – |
| PHGE | Biomx Inc | $4,200,000 | -27.7% | 600,000 | 0.0% | 0.18% | -17.4% | |
| ARGX | argenx SEsponsored adr | $4,183,000 | -17.9% | 31,752 | 0.0% | 0.18% | -6.2% | |
| Vivus Inc 4.5 05/01/2020note4.500% 5/0 | $2,973,000 | +1.9% | 4,000,000 | 0.0% | 0.13% | +16.4% | ||
| PSNL | Personalis Inc | $2,058,000 | -26.0% | 255,000 | 0.0% | 0.09% | -15.2% | |
| PROF | New | Profound Med Corp | $1,697,000 | – | 174,193 | +100.0% | 0.07% | – |
| FLGT | Fulgent Genetics Inc | $807,000 | -16.6% | 75,000 | 0.0% | 0.04% | -5.4% | |
| MOTS | Motus Gi Hldgs Inc | $523,000 | -70.6% | 775,640 | 0.0% | 0.02% | -65.7% | |
| TWST | New | Twist Bioscience Corp | $469,000 | – | 15,324 | +100.0% | 0.02% | – |
| VRAY | Viewray Inc | $375,000 | -40.8% | 150,000 | 0.0% | 0.02% | -33.3% | |
| PHGEWS | BiomX Inc*w exp 10/16/202 | $360,000 | +25.0% | 600,000 | 0.0% | 0.02% | +36.4% | |
| PODD | Exit | Insulet Corp | $0 | – | -67,725 | -100.0% | -0.44% | – |
| A | Exit | Agilent Technologies Inc | $0 | – | -149,690 | -100.0% | -0.48% | – |
| ACHN | Exit | Achillion Pharmaceuticals In | $0 | – | -7,309,383 | -100.0% | -1.66% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS INC | 36 | Q3 2023 | 19.7% |
| MASIMO CORP | 32 | Q3 2023 | 5.8% |
| LA JOLLA PHARMACEUTICAL CO | 31 | Q2 2022 | 9.7% |
| REGENXBIO INC | 30 | Q4 2022 | 10.8% |
| AGENUS INC | 29 | Q2 2022 | 9.0% |
| PTC THERAPEUTICS INC | 28 | Q3 2023 | 12.8% |
| DICERNA PHARMACEUTICALS INC | 28 | Q3 2021 | 10.8% |
| MIRATI THERAPEUTICS INC | 26 | Q3 2023 | 6.2% |
| ARGENX SE | 26 | Q3 2023 | 5.3% |
| VERICEL CORP | 24 | Q3 2023 | 3.9% |
View RTW INVESTMENTS, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | September 19, 2023 | 18,188,457 | - |
| ALLURION TECHNOLOGIES, INC. | August 11, 2023 | 3,457,707 | 7.4% |
| Orchestra BioMed Holdings, Inc. | May 05, 2023 | 5,620,645 | 15.7% |
| Renovacor, Inc.Sold out | April 05, 2023 | 0 | - |
| Adverum Biotechnologies, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Aptevo Therapeutics Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ASLAN Pharmaceuticals LtdSold out | February 14, 2023 | 0 | 0.0% |
| Athira Pharma, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| BELLUS Health Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Clearside Biomedical, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
View RTW INVESTMENTS, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-03-01 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View RTW INVESTMENTS, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.